Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck

Purpose: We sought to evaluate the efficacy and safety of the combination of cetuximab (Cmab) and paclitaxel (PTX) in patients with squamous cell carcinoma of the head and neck (SCCHN) who had unresectable recurrent or metastatic (R/M) disease after platinum-based chemoradiotherapy. Materials and Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Enokida, Tomohiro, Okano, Susumu, Fujisawa, Takao, Ueda, Yuri, Uozumi, Shinya, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119881/
https://www.ncbi.nlm.nih.gov/pubmed/30211118
http://dx.doi.org/10.3389/fonc.2018.00339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119881/
https://www.ncbi.nlm.nih.gov/pubmed/30211118
http://dx.doi.org/10.3389/fonc.2018.00339

Ejemplares similares